Trials / Conditions / Clostridium Difficile Infection (CDI)
Clostridium Difficile Infection (CDI)
6 registered clinical trials studyying Clostridium Difficile Infection (CDI).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safe NCT07251127 | Gateway Pharmaceutical LLC | Phase 1 |
| Unknown | Treatment of Mild-moderate Clostridium Difficile Infection (CDI) NCT04121169 | ImmuniMed Inc. | Phase 2 |
| Withdrawn | Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI) NCT04070352 | University of Pittsburgh | — |
| Completed | Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) NCT03244644 | Rebiotix Inc. | Phase 3 |
| Completed | A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infection NCT02692651 | University of Michigan | Phase 4 |
| Completed | Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostr NCT02437591 | Astellas Pharma Europe Ltd. | Phase 4 |